| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Nienke Dekker, Nicole Schmitz, Bart D Peters, Therese A van Amelsvoort, Don H Linszen, Lieuwe de Haa. Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry research. vol 181. issue 1. 2010-04-20. PMID:19962862. |
cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. |
2010-04-20 |
2023-08-12 |
Not clear |
| Nienke Dekker, Nicole Schmitz, Bart D Peters, Therese A van Amelsvoort, Don H Linszen, Lieuwe de Haa. Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry research. vol 181. issue 1. 2010-04-20. PMID:19962862. |
to test the hypothesis that onset of cannabis use in early adolescence in male schizophrenia patients is associated with abnormalities in white matter structure and integrity, we used high resolution structural and diffusion tensor brain images to compare three groups of patients: those who started regular use of cannabis (1) before the age of 15 years (early-onset cannabis users, n = 10) or (2) at the age of 17 years or later (late-onset cannabis users, n = 8), and (3) those who were cannabis naïve (n = 8). |
2010-04-20 |
2023-08-12 |
Not clear |
| Nienke Dekker, Nicole Schmitz, Bart D Peters, Therese A van Amelsvoort, Don H Linszen, Lieuwe de Haa. Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia. Psychiatry research. vol 181. issue 1. 2010-04-20. PMID:19962862. |
our results suggest that the age of onset of cannabis use is not an identifying characteristic for white matter abnormalities in schizophrenia patients; however, our results might indicate a more vulnerable brain structure in cannabis naïve schizophrenia patients. |
2010-04-20 |
2023-08-12 |
Not clear |
| J Favro. [Motivational interventions: psychosis and cannabis]. L'Encephale. vol 35 Suppl 6. 2010-03-26. PMID:20141773. |
cannabis use by people suffering from schizophrenia increase relapse rate and reduce adhesion to treatment. |
2010-03-26 |
2023-08-12 |
Not clear |
| Thomas Wobrock, Alkomiet Hasan, Berend Malchow, Claus Wolff-Menzler, Birgit Guse, Nicolas Lang, Thomas Schneider-Axmann, Ullrich K H Ecker, Peter Falka. Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse. Psychopharmacology. vol 208. issue 3. 2010-03-23. PMID:19997844. |
increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse. |
2010-03-23 |
2023-08-12 |
human |
| Matt Hickman, Peter Vickerman, John Macleod, Glyn Lewis, Stan Zammit, James Kirkbride, Peter Jone. If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction (Abingdon, England). vol 104. issue 11. 2010-03-17. PMID:19832786. |
if cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? |
2010-03-17 |
2023-08-12 |
Not clear |
| Matt Hickman, Peter Vickerman, John Macleod, Glyn Lewis, Stan Zammit, James Kirkbride, Peter Jone. If cannabis caused schizophrenia--how many cannabis users may need to be prevented in order to prevent one case of schizophrenia? England and Wales calculations. Addiction (Abingdon, England). vol 104. issue 11. 2010-03-17. PMID:19832786. |
we consider how many cannabis users may need to be prevented in order to prevent one case of schizophrenia or psychosis [defined as number needed to prevent (nnp)]. |
2010-03-17 |
2023-08-12 |
Not clear |
| Bart D Peters, Pelle de Koning, Peter Dingemans, Hiske Becker, Don H Linszen, Lieuwe de Haa. Subjective effects of cannabis before the first psychotic episode. The Australian and New Zealand journal of psychiatry. vol 43. issue 12. 2010-02-19. PMID:20001415. |
the aim of the present study was to gain more insight into the positive and negative effects of cannabis in the prodromal phase of schizophrenia and in the ultra-high-risk (uhr) state for psychosis. |
2010-02-19 |
2023-08-12 |
Not clear |
| Daniela Vigano, Cinzia Guidali, Stefania Petrosino, Natalia Realini, Tiziana Rubino, Vincenzo Di Marzo, Daniela Parolar. Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. The international journal of neuropsychopharmacology. vol 12. issue 5. 2010-02-12. PMID:18789179. |
recent advances in the neurobiology of cannabinoids have renewed interest in the association between cannabis and schizophrenia. |
2010-02-12 |
2023-08-12 |
rat |
| Teena M McGuinnes. Update on marijuana. Journal of psychosocial nursing and mental health services. vol 47. issue 10. 2010-01-15. PMID:19835316. |
cannabis abuse is a risk factor for psychosis in genetically predisposed people and may lead to a worse outcome of schizophrenia. |
2010-01-15 |
2023-08-12 |
Not clear |
| Emilio Fernandez-Espejo, Maria-Paz Viveros, Luis Núñez, Bart A Ellenbroek, Fernando Rodriguez de Fonsec. Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology. vol 206. issue 4. 2010-01-14. PMID:19629449. |
role of cannabis and endocannabinoids in the genesis of schizophrenia. |
2010-01-14 |
2023-08-12 |
Not clear |
| Emilio Fernandez-Espejo, Maria-Paz Viveros, Luis Núñez, Bart A Ellenbroek, Fernando Rodriguez de Fonsec. Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology. vol 206. issue 4. 2010-01-14. PMID:19629449. |
cannabis abuse and endocannabinoids are associated to schizophrenia. |
2010-01-14 |
2023-08-12 |
Not clear |
| Else-Marie Løberg, Kenneth Hugdah. Cannabis use and cognition in schizophrenia. Frontiers in human neuroscience. vol 3. 2009-12-16. PMID:19956405. |
cannabis use and cognition in schizophrenia. |
2009-12-16 |
2023-08-12 |
Not clear |
| Else-Marie Løberg, Kenneth Hugdah. Cannabis use and cognition in schizophrenia. Frontiers in human neuroscience. vol 3. 2009-12-16. PMID:19956405. |
people with schizophrenia frequently report cannabis use, and cannabis may be a risk factor for schizophrenia, mediated through effects on brain function and biochemistry. |
2009-12-16 |
2023-08-12 |
Not clear |
| Else-Marie Løberg, Kenneth Hugdah. Cannabis use and cognition in schizophrenia. Frontiers in human neuroscience. vol 3. 2009-12-16. PMID:19956405. |
we report data from our own laboratory on the use of cannabis by schizophrenia patients, and review the existing literature on the effects of cannabis on cognition in schizophrenia and related psychosis. |
2009-12-16 |
2023-08-12 |
Not clear |
| Else-Marie Løberg, Kenneth Hugdah. Cannabis use and cognition in schizophrenia. Frontiers in human neuroscience. vol 3. 2009-12-16. PMID:19956405. |
of the 23 studies that were found, 14 reported that the cannabis users had better cognitive performance than the schizophrenia non-users. |
2009-12-16 |
2023-08-12 |
Not clear |
| Else-Marie Løberg, Kenneth Hugdah. Cannabis use and cognition in schizophrenia. Frontiers in human neuroscience. vol 3. 2009-12-16. PMID:19956405. |
we suggest that cannabis causes a transient cognitive breakdown enabling the development of psychosis, imitating the typical cognitive vulnerability seen in schizophrenia. |
2009-12-16 |
2023-08-12 |
Not clear |
| X Laqueill. [Is cannabis a vulnerability factor in schizophrenic disorders]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie. vol 16. issue 9. 2009-12-03. PMID:19640690. |
cannabis has effects that are close to the symptoms of schizophrenia. |
2009-12-03 |
2023-08-12 |
human |
| Deepak Cyril D'Souza, Richard Andrew Sewell, Mohini Ranganatha. Cannabis and psychosis/schizophrenia: human studies. European archives of psychiatry and clinical neuroscience. vol 259. issue 7. 2009-11-23. PMID:19609589. |
it is likely that cannabis exposure is a "component cause" that interacts with other factors to "cause" schizophrenia or a psychotic disorder, but is neither necessary nor sufficient to do so alone. |
2009-11-23 |
2023-08-12 |
human |
| Deepak Cyril D'Souz. Cannabinoids and psychosis. International review of neurobiology. vol 78. 2009-11-13. PMID:17349865. |
on the other hand, the large majority of individuals exposed to cannabinoids do not experience psychosis or develop schizophrenia and the rates of schizophrenia have not increased commensurate with the increase in rates of cannabis use. |
2009-11-13 |
2023-08-12 |
Not clear |